Doxibecel Tablet 500 mg (Dovecis Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disorders: Administer 750mg daily for 1~3 weeks, then 500mg daily thereafter. Administer after meals with plenty of fluids. Adjust the dose as appropriate according to age and symptoms.

This medication contains Dovecis Calcium Hydrate as the active ingredient and should not be used in certain patients. First, those who have an allergic reaction to this medication or its components should not take it. Also, women who are pregnant or breastfeeding should not take this medication. Since this medication contains lactose, patients who are genetically unable to digest lactose should also avoid taking it. Care should be taken when using this medication in patients with impaired kidney function. Especially, patients with severe kidney disease requiring dialysis may need to reduce the dosage of the medication. Patients with decreased liver function should also be cautious when using this medication, and treatment should be re-evaluated if liver enzyme levels rise significantly. This medication contains metabisulfite, so patients with allergies to metabisulfites or asthma should be careful, as they may experience severe allergic reactions or asthma attacks. Possible side effects that may occur while taking this medication include headache, abdominal pain, nausea, diarrhea, vomiting, joint pain, muscle pain, and elevated liver enzymes. Rarely, allergic reactions such as skin rash, itching, urticaria, and facial swelling or severe anaphylaxis may occur. If symptoms such as high fever, sore throat, or frequent signs of infection occur during treatment with this medication, the doctor should be informed immediately, and a blood test should be conducted to check white blood cell levels. If these symptoms appear, the medication should be discontinued. If hypersensitivity reactions occur, discontinue use immediately and consult a healthcare provider. There are no known special interactions with other medications, but this medication may affect the measurement of creatinine levels during blood tests, so it should be reported before testing. Before starting this medication, necessary tests such as blood tests should be conducted to ensure safe use of the medication.

• Agranulocytosis
• neutropenia
• leukopenia
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial edema
• anaphylactic reaction
• headache

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is advisable to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy for a longer period.

Appearance

White oblong tablet

Package unit

30 tablets/bottle, 90 tablets/bottle